Latest news
{{'Fri, 06 Nov 2026 15:07:00 -0500' | dateFormatUsFilter}}
Novo real-world studies link Wegovy® 2.4 mg to reductions in liver enzymes, weight, and blood sugar in adults with MASH at The Liver Meeting® (AASLD) 2026
Read more
{{'Wed, 04 Nov 2026 07:00:00 -0500' | dateFormatUsFilter}}
Financial report for the period 1 January 2026 to 30 September 2026
Read more
{{'Thu, 29 Oct 2026 08:00:00 -0400' | dateFormatUsFilter}}
Novo to present new CagriSema and Wegovy® data at ObesityWeek® 2026, including data on treatment experience with Wegovy® pill in the real world
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.